DE3581465D1 - Pyridazinonderivate, deren herstellung und verwendung. - Google Patents
Pyridazinonderivate, deren herstellung und verwendung.Info
- Publication number
- DE3581465D1 DE3581465D1 DE8585307364T DE3581465T DE3581465D1 DE 3581465 D1 DE3581465 D1 DE 3581465D1 DE 8585307364 T DE8585307364 T DE 8585307364T DE 3581465 T DE3581465 T DE 3581465T DE 3581465 D1 DE3581465 D1 DE 3581465D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- production
- pyridazine derivatives
- variety
- potentiate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical class C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
- 208000020446 Cardiac disease Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59213968A JPS6193169A (ja) | 1984-10-12 | 1984-10-12 | ピリダジノン誘導体及びその製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3581465D1 true DE3581465D1 (de) | 1991-02-28 |
Family
ID=16648043
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8585307364T Expired - Fee Related DE3581465D1 (de) | 1984-10-12 | 1985-10-14 | Pyridazinonderivate, deren herstellung und verwendung. |
| DE89105964T Expired - Fee Related DE3587596T2 (de) | 1984-10-12 | 1985-10-14 | Pyridazinon-Derivate, deren Herstellung und Verwendung. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE89105964T Expired - Fee Related DE3587596T2 (de) | 1984-10-12 | 1985-10-14 | Pyridazinon-Derivate, deren Herstellung und Verwendung. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4914093A (enExample) |
| EP (2) | EP0330242B1 (enExample) |
| JP (1) | JPS6193169A (enExample) |
| KR (1) | KR900002059B1 (enExample) |
| AT (2) | ATE94874T1 (enExample) |
| DE (2) | DE3581465D1 (enExample) |
| ES (1) | ES8702371A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0613483B2 (ja) * | 1985-11-12 | 1994-02-23 | 三共株式会社 | フエニルピリダジノン誘導体 |
| JPS6314774A (ja) * | 1986-07-07 | 1988-01-21 | Mitsubishi Chem Ind Ltd | ピリダジノン誘導体又はその塩類 |
| US5019612A (en) * | 1986-10-06 | 1991-05-28 | Ciba-Geigy Corporation | 6-(4-hydroxyphenyl)-4,5-dihydro-3(2H)-pyridazinones and stabilized compositions |
| US4888423A (en) * | 1986-10-06 | 1989-12-19 | Ciba-Geigy Corporation | 6-(4-Hydroxyphenyl)-4,5-dihydro-3(2h)-pyridazinones and stabilized compositions |
| DE3728491A1 (de) * | 1987-08-26 | 1989-03-09 | Heumann Pharma Gmbh & Co | Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5198448A (en) * | 1988-08-10 | 1993-03-30 | Otsuka Pharmaceutical Company, Limited | Cardiotonics |
| DE3902316A1 (de) * | 1989-01-26 | 1990-08-02 | Lentia Gmbh | Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel |
| US5175161A (en) * | 1989-04-06 | 1992-12-29 | Sankyo Company, Limited | Occular hypotensive agents |
| US5273976A (en) * | 1989-04-06 | 1993-12-28 | Sankyo Company, Limited | Ocular hypotensive agents |
| IE902881A1 (en) * | 1989-08-10 | 1991-02-27 | Glaxo Inc | Pyridazinones having cardiotonic and beta blocking¹activities |
| US5204463A (en) * | 1989-08-10 | 1993-04-20 | Glaxo Inc. | Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities |
| US5096904A (en) * | 1989-09-01 | 1992-03-17 | Glaxo Inc. | Pyridazinones having cardiotonic and beta blocking activities |
| US5153209A (en) * | 1989-09-22 | 1992-10-06 | Glaxo Inc. | Pyridone nitriles useful in treating cardiovascular disease |
| US5051431A (en) * | 1989-09-22 | 1991-09-24 | Glaxo Inc. | Pyridone nitriles useful in treating cardiovascular disease |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| IL118631A (en) * | 1995-06-27 | 2002-05-23 | Tanabe Seiyaku Co | History of pyridazinone and processes for their preparation |
| WO2004050657A2 (en) * | 2002-11-27 | 2004-06-17 | Artesian Therapeutics, Inc. | COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| WO2004058726A2 (en) * | 2002-12-23 | 2004-07-15 | Artesian Therapeutics, Inc. | CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE |
| US20080090827A1 (en) * | 2004-11-30 | 2008-04-17 | Artesian Therapeutics, Inc. | Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| EP1833480A2 (en) * | 2004-11-30 | 2007-09-19 | Artesian Therapeutics, Inc. | Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| JP2006181097A (ja) * | 2004-12-27 | 2006-07-13 | Mammy's:Kk | 売り場構造及び商品陳列方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
| GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
| JPS588015A (ja) * | 1981-07-06 | 1983-01-18 | Mitsubishi Chem Ind Ltd | 強心剤 |
| US4816454A (en) * | 1984-09-21 | 1989-03-28 | Cassella Aktiengesellschaft | 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use |
-
1984
- 1984-10-12 JP JP59213968A patent/JPS6193169A/ja active Granted
-
1985
- 1985-10-11 ES ES547826A patent/ES8702371A1/es not_active Expired
- 1985-10-12 KR KR1019850007521A patent/KR900002059B1/ko not_active Expired
- 1985-10-14 DE DE8585307364T patent/DE3581465D1/de not_active Expired - Fee Related
- 1985-10-14 DE DE89105964T patent/DE3587596T2/de not_active Expired - Fee Related
- 1985-10-14 AT AT89105964T patent/ATE94874T1/de active
- 1985-10-14 EP EP89105964A patent/EP0330242B1/en not_active Expired - Lifetime
- 1985-10-14 AT AT85307364T patent/ATE60324T1/de not_active IP Right Cessation
- 1985-10-14 EP EP85307364A patent/EP0178189B1/en not_active Expired - Lifetime
-
1989
- 1989-03-16 US US07/325,112 patent/US4914093A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0178189A2 (en) | 1986-04-16 |
| JPS6193169A (ja) | 1986-05-12 |
| EP0178189A3 (en) | 1987-03-04 |
| DE3587596D1 (de) | 1993-10-28 |
| KR860003232A (ko) | 1986-05-21 |
| ATE94874T1 (de) | 1993-10-15 |
| ATE60324T1 (de) | 1991-02-15 |
| KR900002059B1 (ko) | 1990-03-31 |
| US4914093A (en) | 1990-04-03 |
| ES8702371A1 (es) | 1986-12-16 |
| ES547826A0 (es) | 1986-12-16 |
| DE3587596T2 (de) | 1994-05-11 |
| JPH0557983B2 (enExample) | 1993-08-25 |
| EP0178189B1 (en) | 1991-01-23 |
| EP0330242A1 (en) | 1989-08-30 |
| EP0330242B1 (en) | 1993-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3581465D1 (de) | Pyridazinonderivate, deren herstellung und verwendung. | |
| ATE40884T1 (de) | Zwischenverbindungen fuer die herstellung von omeprazol. | |
| DK399588D0 (da) | Pentasaccharider | |
| DE3881408D1 (de) | Thiazolidinon-derivate, ihre herstellung und ihre verwendung. | |
| SE8804036L (sv) | Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma | |
| ATE102930T1 (de) | Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend. | |
| ES2131830T3 (es) | Benzamidinas sustituidas, su preparacion y uso como medicamentos. | |
| ES8703472A1 (es) | Procedimiento para preparar nuevos derivados imidazo | |
| ES2031892T3 (es) | Agentes antialergicos y antiinflamatorios. | |
| DE3576957D1 (de) | Carbapenemverbindungen, deren herstellung und verwendung. | |
| DE3775666D1 (de) | Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung. | |
| EP0159040A3 (en) | Pyridine derivatives and production thereof | |
| ATE66476T1 (de) | Thianaphthen-derivate, ihre herstellung und verwendung. | |
| ATE29024T1 (de) | Bicyclooctanderivate, ihre herstellung und ihre verwendung. | |
| DK7286D0 (da) | Octahydroindoliziner | |
| ATE104967T1 (de) | Imidazolderivate, deren herstellung und therapeutische verwendung. | |
| FI870460A0 (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter. | |
| ES8602775A1 (es) | Procedimiento para fotoestabilizar molsidomina | |
| WO1987005601A3 (fr) | Sulfonamides derives de diarylmethanes et leurs utilisations comme medicaments | |
| ATE64921T1 (de) | Benzochinonderivate, ihre herstellung und verwendung. | |
| DE3666430D1 (en) | Condensed seven-membered heterocyclic compounds, their production and use | |
| ES8708226A1 (es) | Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina | |
| ATE77362T1 (de) | Naphthalenische antipsoriasismittel und ihr herstellungsverfahren. | |
| FI842639L (fi) | Acylderivat av 1,4,3,6-dianhydro- hexitol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |